These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17505515)

  • 61. Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins.
    Michaelis M; Bliss J; Arnold SC; Hinsch N; Rothweiler F; Deubzer HE; Witt O; Langer K; Doerr HW; Wels WS; Cinatl J
    Clin Cancer Res; 2008 Oct; 14(20):6531-7. PubMed ID: 18927293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling.
    Tsuchida R; Das B; Yeger H; Koren G; Shibuya M; Thorner PS; Baruchel S; Malkin D
    Oncogene; 2008 Jun; 27(28):3923-34. PubMed ID: 18332870
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
    Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
    Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells.
    Hrabeta J; Groh T; Khalil MA; Poljakova J; Adam V; Kizek R; Uhlik J; Doktorova H; Cerna T; Frei E; Stiborova M; Eckschlager T
    Int J Oncol; 2015 Sep; 47(3):971-80. PubMed ID: 26134421
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX; Luo Y; Qiu HM; Tang WX
    Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
    Muleya JS; Nakaichi M; Taura Y; Yamaguchi R; Nakama S
    Res Vet Sci; 1999 Jun; 66(3):169-74. PubMed ID: 10333454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Suppression of multidrug resistance by migrastatin.
    Takemoto Y; Tashiro E; Imoto M
    J Antibiot (Tokyo); 2006 Jul; 59(7):435-8. PubMed ID: 17025021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF; Xiao C; Li H; Yang SJ
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
    Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Identifying the Importance of MT-3 Expression for Neuroblastoma Cells].
    Eckschlager T; Vícha A; Jenčová P; Merlos R; Dostálová S; Buchtelová H; Strmiska V; Michálek P; Heger Z; Adam V
    Klin Onkol; 2018; 31(Supplementum1):145-147. PubMed ID: 29808689
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells.
    Poomthavorn P; Wong SH; Higgins S; Werther GA; Russo VC
    Endocr Relat Cancer; 2009 Sep; 16(3):991-1004. PubMed ID: 19423615
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of xenobiotic efflux transporters in resistance to vincristine.
    Huang RS; Murry DJ; Foster DR
    Biomed Pharmacother; 2008 Feb; 62(2):59-64. PubMed ID: 17583464
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overcoming of vincristine resistance in HL-60 human promyelocytic leukemia cell line by dipyridamole.
    Hirose M; Takeda E; Kuroda Y
    Tokushima J Exp Med; 1993 Jun; 40(1-2):27-33. PubMed ID: 8211977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sodium valproate inhibits in vivo growth of human neuroblastoma cells.
    Cinatl J; Cinatl J; Driever PH; Kotchetkov R; Pouckova P; Kornhuber B; Schwabe D
    Anticancer Drugs; 1997 Nov; 8(10):958-63. PubMed ID: 9436639
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suppression of vincristine-mediated cytotoxic activity by mitoxantrone in human cell lines.
    Ho CK; Au LC; Wang SY
    Anticancer Res; 1996; 16(5A):2645-51. PubMed ID: 8917364
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line.
    Yasuno T; Matsumura T; Shikata T; Inazawa J; Sakabe T; Tsuchida S; Takahata T; Miyairi S; Naganuma A; Sawada T
    Anticancer Res; 1999; 19(5B):4049-57. PubMed ID: 10628353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug resistance and cross-sensitivity in cultured human osteosarcoma cells.
    Tomita K; Kontani T; Tsuchiya H; Nomura S
    Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):274-81. PubMed ID: 2738428
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma.
    Rodrigo MAM; Michalkova H; Strmiska V; Casar B; Crespo P; de Los Rios V; Ignacio Casal J; Haddad Y; Guran R; Eckschlager T; Pokorna P; Heger Z; Adam V
    Sci Rep; 2021 Mar; 11(1):5496. PubMed ID: 33750814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.